CHK1 INHIBITION RESTORES INOTUZUMAB OZOGAMICIN CITOTOXICITY ON CD22-POSITIVE CELLS EXPRESSING MUTANT P53

被引：0

作者：

Tirro, E. ^{[1
,2
]}

Massimino, M. ^{[1
,2
]}

Manzella, L. ^{[1
,2
]}

Parrinello, N. L. ^{[3
]}

Stagno, F. ^{[3
]}

Palumbo, G. A. ^{[3
]}

Romano, A. ^{[3
]}

Di Raimondo, F. ^{[3
]}

Vigneri, P. ^{[1
,2
]}

机构：

[1] Univ Catania, Dept Clin & Expt Med, Catania, Italy

[2] AOU Policlin Vittorio Emanuele, Ctr Expt Oncol & Hematol, Catania, Italy

[3] Univ Catania, Div Hematol, AOU Policlin Vittorio Emanuele, Catania, Italy

来源：

HAEMATOLOGICA | 2018年 / 103卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO073

引用

页码：S104 / S104

页数：1

共 50 条

[11] Chk1 Inhibition Enhances Cisplatin Cytotoxicity Regardless of p53 Status in Human Small Cell Lung Cancer Cells [J].

Hsu, Wei-Hsun ;

Hsu, Shuo-Tse ;

Rao, Guanhua ;

Kim, In-Gyu ;

Alberobello, Anna T. ;

Wang, Yisong ;

Giaccone, Giuseppe .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S399-S399

[12] Chk1/2 Inhibition Overcomes the Cisplatin Resistance of Head and Neck Cancer Cells Secondary to the Loss of Functional p53 [J].

Gadhikar, Mayur A. ;

Sciuto, Maria Rita ;

Alves, Marcus Vinicius Ortega ;

Pickering, Curtis R. ;

Osman, Abdullah A. ;

Neskey, David M. ;

Zhao, Mei ;

Fitzgerald, Alison L. ;

Myers, Jeffrey N. ;

Frederick, Mitchell J. .

MOLECULAR CANCER THERAPEUTICS, 2013, 12 (09) :1860-1873

[13] Phase I Study of Inotuzumab Ozogamicin in Children with Relapsed/Refractory CD22-Positive Acute Lymphoblastic Leukemia in Japan (Ino-Ped-All-1) [J].

Nakayama, Hideki ;

Ogawa, Chitose ;

Sekimizu, Masahiro ;

Fujisaki, Hiroyuki ;

Kosaka, Yoshiyuki ;

Hashimoto, Hiroya ;

Saito, Akiko ;

Horibe, Keizo .

PEDIATRIC BLOOD & CANCER, 2021, 68

[14] Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway [J].

Vitale, Ilio ;

Galluzzi, Lorenzo ;

Vivet, Sonia ;

Nanty, Lisa ;

Dessen, Philippe ;

Senovilla, Laura ;

Olaussen, Ken A. ;

Lazar, Vladimir ;

Prudhomme, Michelle ;

Golsteyn, Roy M. ;

Castedo, Maria ;

Kroemer, Guido .

PLOS ONE, 2007, 2 (12)

[15] Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells [J].

Origanti, S. ;

Cai, S-R ;

Munir, A. Z. ;

White, L. S. ;

Piwnica-Worms, H. .

ONCOGENE, 2013, 32 (05) :577-588

[16] Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells [J].

S Origanti ;

S-r Cai ;

A Z Munir ;

L S White ;

H Piwnica-Worms .

Oncogene, 2013, 32 :577-588

[17] Chk1 inhibition-induced BRCAness synergizes with olaparib in p53-deficient cancer cells [J].

Zhao, Yang ;

Zhou, Kehui ;

Xia, Xiangyu ;

Guo, Yajie ;

Tao, Li .

CELL CYCLE, 2023, 22 (02) :200-212

[18] Mafosfamide induced apoptosis in human lymphoblastoid cells: Role of DNA replication, RNA transcription, p53 and Chk1/Chk2 [J].

Goldstein, M. ;

Roos, W. P. ;

Kaina, B. .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 :82-82

[19] Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells [J].

Kalli Koniaras ;

Andrew R Cuddihy ;

Helen Christopoulos ;

Annette Hogg ;

Matthew J O'Connell .

Oncogene, 2001, 20 :7453-7463

[20] Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells [J].

Koniaras, K ;

Cuddihy, AR ;

Christopoulos, H ;

Hogg, A ;

O'Connell, MJ .

ONCOGENE, 2001, 20 (51) :7453-7463

← 1 2 3 4 5 →